Afya (AFYA) Q2 FY26 earnings call

Afya delivered solid first-half 2026 results, driven by strong medical education growth and a commitment to shareholder returns, with BRL 448 million returned to shareholders. While adjusted EBITDA margins faced pressure from strategic investments in continued education and medical practice solutions, the company maintained healthy profitability and strong cash generation, enabling both internal product enhancements and capital returns.